A detailed history of Omers Administration Corp transactions in Alkermes Plc. stock. As of the latest transaction made, Omers Administration Corp holds 57,900 shares of ALKS stock, worth $1.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
57,900
Previous 57,900 -0.0%
Holding current value
$1.63 Million
Previous $1.4 Million 16.13%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$23.21 - $27.24 $522,225 - $612,900
22,500 Added 63.56%
57,900 $1.4 Million
Q1 2024

May 14, 2024

BUY
$26.4 - $32.56 $696,960 - $859,584
26,400 Added 293.33%
35,400 $958,000
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $210,330 - $258,120
9,000 New
9,000 $249,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.61B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.